- Home
- ARVN vs TCBX Comparison
ARVN vs TCBX Comparison
Compare ARVN & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- TCBX
- Stock Information
- Founded
- ARVN 2015
- TCBX 2008
- Country
- ARVN United States
- TCBX United States
- Employees
- ARVN N/A
- TCBX N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- TCBX Banks
- Sector
- ARVN Health Care
- TCBX Finance
- Exchange
- ARVN Nasdaq
- TCBX Nasdaq
- Market Cap
- ARVN 456.2M
- TCBX 454.9M
- IPO Year
- ARVN 2018
- TCBX 2021
- Fundamental
- Price
- ARVN $7.80
- TCBX $32.23
- Analyst Decision
- ARVN Buy
- TCBX Hold
- Analyst Count
- ARVN 21
- TCBX 4
- Target Price
- ARVN $20.53
- TCBX $33.67
- AVG Volume (30 Days)
- ARVN 2.2M
- TCBX 49.8K
- Earning Date
- ARVN 07-29-2025
- TCBX 07-23-2025
- Dividend Yield
- ARVN N/A
- TCBX N/A
- EPS Growth
- ARVN N/A
- TCBX 44.43
- EPS
- ARVN N/A
- TCBX 2.95
- Revenue
- ARVN $426,900,000.00
- TCBX $172,270,000.00
- Revenue This Year
- ARVN $4.26
- TCBX $17.44
- Revenue Next Year
- ARVN N/A
- TCBX $6.46
- P/E Ratio
- ARVN N/A
- TCBX $10.88
- Revenue Growth
- ARVN 498.74
- TCBX 17.40
- 52 Week Low
- ARVN $5.90
- TCBX $19.52
- 52 Week High
- ARVN $34.11
- TCBX $39.45
- Technical
- Relative Strength Index (RSI)
- ARVN 58.03
- TCBX 60.65
- Support Level
- ARVN $7.09
- TCBX $29.98
- Resistance Level
- ARVN $7.85
- TCBX $32.57
- Average True Range (ATR)
- ARVN 0.40
- TCBX 0.98
- MACD
- ARVN 0.06
- TCBX 0.17
- Stochastic Oscillator
- ARVN 71.43
- TCBX 88.32
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.